Researchers
Popović, Lazar
Results 21-40 of 80
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2024 | Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study | Rizzo, Mimma; ...; Popovic, Lazar S   ; ...; (broj, koautora 34) | Article | 21M21 |
| 2023 | Twelve ESMO Congress 2022 breakthroughs: practicing oncologists' perceptions and potential application on presented data | Van, Halteren HK; Bennouna, J; Brasiuniene, B; Tomas, Cunquero AJ; Trinidad, Garcia AM; Indini, A; Liposits, G; Pellegrino, B; Popovic, Lazar ; Tan, A;
Vidra, R; Strijbos, M; Practising Oncologists Working Grp;
| Article | 21aM21a |
| 2023 | Targeting triple-negative breast cancer: A clinical perspective | Popovic, Lazar S ; Matovina-Brko, Gorana ; Popovic, Maja ; Punie, Kevin; Cvetanovic, Ana ; Lambertini, Matteo | Article | 21M21 |
| 2023 | Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs | Bencina, Goran; Chami, Nour; Hughes, Robert; Weston, Georgie; Baxter, Carl; Maciejczyk, Adam; Popovic, Lazar S ; Karamousouli, Eugenia; Salomonsson, Stina | Article | 21M21 |
| 2023 | Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study | Fiala, Ondrej; ...; Popovic, Lazar S ; ...; (broj, koautora 92) | Article | 21M21 |
| 2023 | Cancer-associated stroke in a patient with testicular cancer - case report | Jovicevic, Masa; Jovicevic, Predrag; Zivanovic, Zeljko ; Boskovic, Ksenija ; Popovic, Maja; Popovic, Lazar | Article | 52M52 |
| 2023 | The Role of Isoflavones in the Prevention of Breast Cancer and Prostate Cancer | Pejčić, Tomislav ; Zeković, Milica ; Bumbaširević, Uroš ; Kalaba, Milica ; Vovk, Irena; Bensa, Maja; Popović, Lazar ; Tešić, Živoslav | Article | 21a+M21a+ |
| 2023 | Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study | Matteo Santoni; Zin W Myint; Thomas Büttner; Hideki Takeshita; Yohei Okada; Elaine T Lam; ... et al; Popovic, Lazar S ; (broj, koautora 43) | Article | 21M21 |
| 2023 | Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting | Pejčić, Tomislav ; Todorović, Zoran ; Đurašević, Siniša ; Popović, Lazar | Article | 21M21 |
| 2022 | Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study | Tan, Antoinette R; Wright, Gail; Thummala, Anu; Danso, Michael; Popovic, Lazar S ; Pluard, Timothy; ...et al.; Milenkovic, Dusan M; (broj, koautora 17) | Article | 21a+M21a+ |
| 2022 | Fenomen fantomskog bola kod onkološkog bolesnika sa rabdomiosarkomom: prikaz slučaja | Jović, Maša; Jovićević, Predrag; Popović, Lazar ; Bošković, Ksenija ; Zvekić-Svorcan, Jelena | Conference Paper | Mp. category will be shown later |
| 2022 | Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approach | Mauri, Davide; Kamposioras, Konstantinos; Matthaios, Dimitrios; Tolia, Maria; ...et al.; Popovic, Lazar S ; (broj, koautora 26) | Article | 22M22 |
| 2022 | COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information | Mauri, Davide; ...; Popovic, Lazar S ; ...; Djan, Igor ; ...; (broj, koautora 54) | Article | 22M22 |
| 2022 | The Clinical Benefit of Percutaneous Transhepatic Biliary Drainage for Malignant Biliary Tract Obstruction | Nikolić, Ivan V ; Radić, Jelena P ; Petreš, Andrej V; Đurić, Aleksandar; Protić, Mlađan ; Litavski, Jelena; Popović, Maja; Kolarov-Bjelobrk, Ivana N ; Dragin, Saša B ; Popović, Lazar S | Article | 21M21 |
| 2022 | Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer | Agostinetto, Elisa; Losurdo, Agnese; Nader-Marta, Guilherme; Santoro, Armando; Punie, Kevin; Barroso, Romualdo; Popovic, Lazar S ; Solinas, Cinzia; Kok, Marleen; De, Azambuja Evandro;
Lambertini, Matteo;
| Article | 21aM21a |
| 2022 | Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma | Popovic, Maja ; Matovina-Brko, Gorana ; Jovic, Masa; Popovic, Lazar S | Article | 22M22 |
| 2021 | Preliminary analysis of a phase II, multicenter, randomized, active-control study to evaluate the efficacy and safety of eganelisib (IPI 549) in combination with nivolumab compared to nivolumab monotherapy in patients with advanced urothelial carcinoma. | Tomczak, Piotr; Popovic, Lazar S ; Barthelemy, Philippe; Janicic, Aleksander; Fernandez, Elena Sevillano; Borchiellini, Delphine; Aglietta, Massimo; Maroto, Jose; Carnot, Aurelien; O'Connell, Brenda;
Zizlsperger, Nora; Zhang, Halle Huihong; Valderrama, Begona P;
| Conference Paper | Mp. category will be shown later |
| 2021 | Immunotherapy in the treatment of lymphoma | Popovic, Lazar S ; Matovina-Brko, Gorana ; Popovic, Maja ; Popovic, Milica S ; Cvetanovic, Ana ; Nikolic, Ivan V ; Kukic, Biljana ; Petrovic, Dragana | Article | 22M22 |
| 2021 | Trilaciclib improves overall survival when given with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: Final analysis of a randomized phase 2 trial | O'Shaughnessy, Joyce; ...; Popovic, Lazar S ; ...; Milenkovic, Dusan M; ...; (broj, koautora 17) | Conference Paper | Mp. category will be shown later |
| 2021 | A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment | Saif Muhammad, Wasif; ...; Popovic, Lazar S ; ...; Zaric, Bojan ; ...; (broj, koautora 17) | Article | 22M22 |